Diagnosis and Management of First Case of COVID-19 in Canada : Lessons Applied From SARS-CoV-1
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
We report diagnosis and management of the first laboratory-confirmed case of coronavirus disease 2019 (COVID-19) hospitalized in Toronto, Canada. No healthcare-associated transmission occurred. In the face of a potential pandemic of COVID-19, we suggest sustainable and scalable control measures developed based on lessons learned from severe acute respiratory syndrome.
| Errataetall: |
CommentIn: Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. - PMID 32147715 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 16 vom: 19. Nov., Seite 2207-2210 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Marchand-Senécal, Xavier [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019-nCoV |
|---|
| Anmerkungen: |
Date Completed 24.11.2020 Date Revised 07.12.2022 published: Print CommentIn: Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. - PMID 32147715 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa227 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307361136 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307361136 | ||
| 003 | DE-627 | ||
| 005 | 20231225125409.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa227 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1024.xml |
| 035 | |a (DE-627)NLM307361136 | ||
| 035 | |a (NLM)32147731 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Marchand-Senécal, Xavier |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnosis and Management of First Case of COVID-19 in Canada |b Lessons Applied From SARS-CoV-1 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.11.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. - PMID 32147715 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
| 520 | |a We report diagnosis and management of the first laboratory-confirmed case of coronavirus disease 2019 (COVID-19) hospitalized in Toronto, Canada. No healthcare-associated transmission occurred. In the face of a potential pandemic of COVID-19, we suggest sustainable and scalable control measures developed based on lessons learned from severe acute respiratory syndrome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a 2019-nCoV | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Infection Prevention | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Kozak, Rob |e verfasserin |4 aut | |
| 700 | 1 | |a Mubareka, Samira |e verfasserin |4 aut | |
| 700 | 1 | |a Salt, Natasha |e verfasserin |4 aut | |
| 700 | 1 | |a Gubbay, Jonathan B |e verfasserin |4 aut | |
| 700 | 1 | |a Eshaghi, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Allen, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Bastien, Natalie |e verfasserin |4 aut | |
| 700 | 1 | |a Gilmour, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Ozaldin, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Leis, Jerome A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 71(2020), 16 vom: 19. Nov., Seite 2207-2210 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2020 |g number:16 |g day:19 |g month:11 |g pages:2207-2210 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa227 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2020 |e 16 |b 19 |c 11 |h 2207-2210 | ||